This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Autosomal Dominant Polycystic Kidney Disease
and you are
between 18 and 50
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to compare the short-term effects of two tolvaptan formulations in patients with ADPKD.

Provided treatments

  • Drug: Tolvaptan MR
  • Drug: Tolvaptan IR
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01451827. The sponsor of the trial is Otsuka Pharmaceutical Development & Commercialization, Inc. and it is looking for 178 volunteers for the current phase.
Official trial title:
A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind, Placebo-masked, Parallel-group Pilot Trial to Compare the Efficacy, Tolerability, and Safety of Tolvaptan Modified-release and Immediate-release Formulations in Subjects With Autosomal Dominant Polycystic Kidney Disease